Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
180
Trial Sponsor
Clinical Trial Start Date
2010
0Primary Completion Date
2013
0Study Completion Date
2013
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Intervention Type
Drug0
Interventional Trial Phase
Not Applicable0
Participating Facility
Official Name
High Risk Prostate Cancer Prevention Study0
Last Updated
January 1, 2014
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
finasteride0
Study summary
The purpose of this study is to study the molecular effects of the chemopreventative agent, finasteride, in combination with dietary soy supplementation in patients at high risk for the development of prostate cancer. Also, the investigators intend to create a large database with health information from men who are at high risk of developing prostate cancer, along with serum and tissue samples from those patients who are willing to provide tissue and serum samples.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
